These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hepatotoxicity after treatment of schistosomiasis with hycanthone. Farid Z; Smith JH; Bassily S; Sparks HA Br Med J; 1972 Apr; 2(5805):88-9. PubMed ID: 5018315 [No Abstract] [Full Text] [Related]
24. [Liver toxicity of laxatives. Results of exposure to phenolisatines]. Henning H; von Braun HH; Look D; Lüders CJ; Vogel HM Z Gastroenterol; 1973 Mar; 11(2):75-84. PubMed ID: 4803412 [No Abstract] [Full Text] [Related]
25. Intravenous amiodarone in intensive care: time for a reappraisal? James PR; Barrera Groba C Intensive Care Med; 2001 Aug; 27(8):1433. PubMed ID: 11511965 [No Abstract] [Full Text] [Related]
26. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Lewis JH; Ranard RC; Caruso A; Jackson LK; Mullick F; Ishak KG; Seeff LB; Zimmerman HJ Hepatology; 1989 May; 9(5):679-85. PubMed ID: 2785079 [TBL] [Abstract][Full Text] [Related]
27. Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha. Lu J; Jones AD; Harkema JR; Roth RA; Ganey PE Toxicol Sci; 2012 Jan; 125(1):126-33. PubMed ID: 21984482 [TBL] [Abstract][Full Text] [Related]
28. Acute hepatitis complicating intravenous amiodarone treatment. Agozzino F; Picca M; Pelosi G Ital Heart J; 2002 Nov; 3(11):686-8. PubMed ID: 12506529 [TBL] [Abstract][Full Text] [Related]
29. [Toxic hepatitis caused by intravenous amiodarone]. Luengo O; Montero J; Alegre J; Fernández Sevilla T Med Clin (Barc); 2000 Dec; 115(20):798-9. PubMed ID: 11171458 [No Abstract] [Full Text] [Related]
30. [Severe hepatotoxicity caused by amiodarone: description of a case]. Latorre G; Lucas I; Herrero JI; Sangro B; Quiroga J; Sola JJ; Díaz L; Prieto J Rev Med Univ Navarra; 1999; 43(2):86-91. PubMed ID: 11256009 [TBL] [Abstract][Full Text] [Related]
36. Hepatic computed tomography changes caused by amiodarone. Kenzaka T Korean J Intern Med; 2015 Sep; 30(5):745-6. PubMed ID: 26354074 [No Abstract] [Full Text] [Related]
37. [Anti-arrhythmic drug therapy in impaired liver function]. Perings C Internist (Berl); 2002 Aug; 43(8):1004-5. PubMed ID: 12243049 [No Abstract] [Full Text] [Related]
38. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone. Hashmi A; Keswani NR; Kim S; Graham DY South Med J; 2016 Feb; 109(2):83-6. PubMed ID: 26840961 [TBL] [Abstract][Full Text] [Related]
39. Use of population modeling to define rational monitoring of amiodarone hepatic effects. Pollak PT; Shafer SL Clin Pharmacol Ther; 2004 Apr; 75(4):342-51. PubMed ID: 15060512 [TBL] [Abstract][Full Text] [Related]
40. Amiodarone-induced hepatitis and polyneuropathy. Kang HM; Kang YS; Kim SH; Seong JK; Kang DY; Lee HY; Lee BS Korean J Intern Med; 2007 Sep; 22(3):225-9. PubMed ID: 17939344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]